Skip to main content
Journal of General Internal Medicine logoLink to Journal of General Internal Medicine
letter
. 2022 Jan 3;37(4):1003–1005. doi: 10.1007/s11606-021-07253-y

The Effect of Redeployment During the COVID-19 Pandemic on Development of Anxiety, Depression, and Insomnia in Healthcare Workers

Maylyn Martinez 1,2,, Nancy H Stewart 3, Anya L Koza 4, Serena Dhaon 5, Christiana Shoushtari 6, Vineet M Arora 5
PMCID: PMC8722745  PMID: 34981365

BACKGROUND

During COVID-19 pandemic surges, many hospitals addressed staffing shortages with redeployment of healthcare workers (HCWs), which increases the number of employees able to care for surging numbers of patients. However, redeployed HCWs may face challenges from working in unfamiliar settings or lack of social support in new clinical environments. Trainees redeployed during the COVID-19 pandemic experienced a negative impact on their education and morale.1 However, few studies have reported on anxiety, depression, and insomnia in redeployed clinicians. We aimed to assess these conditions in HCWs redeployed during the COVID-19 pandemic.

METHODS

From August 31 to September 15, 2020, HCWs were recruited via public Facebook, Twitter, and Instagram accounts to complete an online survey. Self-selection and “healthcare worker” definitions were contingent upon an affirmative answer to, “Have you worked in the clinical setting during the COVID-19 pandemic?” Participants were from all areas of healthcare and training levels. Respondents were asked to consider the “most recent month of greatest clinical intensity and risk of SARS-CoV-2 transmission.” Outcomes included insomnia [Insomnia Severity Index (ISI)2 score of > 14], and anxiety and depression [Patient Health Questionnaire-4 (PHQ-4)3 score ≥ 3]. “Redeployment” was defined as being assigned to a new unit/department or returning to work from retirement. Chi-squared analysis tested for associations of redeployment with age, sex, relationship status, race, ethnicity, profession, career stage, and positive SARS-CoV-2 test with our outcomes. Multivariable logistic regression was used to test for independent association of each outcome with “redeployment” controlling for demographics and preexisting sleep, anxiety, and depressive disorders. p values less than 0.05 were considered statistically significant. All analyses were performed using StataCorp. 2019, Stata Statistical Software: Release 16, College Station, TX: StataCorp LLC.

RESULTS

Of the 1176 respondents who clicked the survey link, 963 (82%) submitted and 931 (79%) reported their redeployment status. Of these, 208 (22.3%) reported “redeployment.” Common redeployment sites included ICU (22.1%), other inpatient (25.0%), outpatient (21.2%), or ER (17.8%). Groups more likely to be redeployed included age < 30 (25.5% vs. 13.0%), single (41.8% vs. 18.3%), Black (17.3% vs. 4.6%), Hispanic (23.1% vs. 10.2%), trainees (24.0% vs. 15.9%), non-physicians (40.9% vs. 28.9%), and those from a rural area (5.4% vs. 4.2%) or town (28.9% vs. 12.2%) (Table 1). Among redeployed HCWs, non-physicians were more likely to have insomnia (63% vs. 36%), anxiety (70% vs. 43%), and depression (68% vs. 35%). Those with positive COVID test were more likely to have insomnia (49% vs. 30%) and anxiety (54% vs. 38%). All were statistically significant at p < 0.05. Being a trainee was not significantly associated with any of the outcomes.

Table 1.

Sample Characteristics

Total
N (%)
Redeployed
N (%)
Not redeployed
N (%)
p value*
Total 931 (100) 208 (22.3) 723 (77.7)
Age group
  18–29 147 (15.8) 53 (25.5) 94 (13.0)  < 0.001
  30–49 690 (74.1) 140 (67.3) 550 (76.1)
  50 +  86 (9.2) 14 (6.7) 72 (10.0)
  Did not answer 8 (0.9) 1 (0.5) 7 (1.0)
Gender
  Male 218 (23.4) 60 (28.9) 158 (21.9) 0.06
  Female 705 (75.7) 145 (69.7) 560 (77.5)
  Did not answer 8 (0.9) 3 (1.4) 5 (0.7)
Race
  Non-Black 862 (92.6) 172 (82.7) 690 (95.4)  < 0.001
  Black 69 (7.4) 36 (17.3) 33 (4.6)
Ethnicity
  Non-Hispanic 757 (81.3) 152 (73.1) 605 (83.7)  < 0.001
  Hispanic 122 (13.1) 48 (23.1) 74 (10.2)
  Did not answer 52 (5.6) 8 (3.4) 44 (6.1)
Significant other
  Yes 697 (72.7) 117 (56.3) 580 (80.2)  < 0.001
  No 219 (22.9) 87 (41.8) 132 (18.3)
  Did not answer 15 (4.5) 4 (1.9) 11 (1.5)
Profession
  Physician 599 (64.3) 123 (59.1) 514 (71.1)  < 0.001
  Non-physician 332 (35.7) 85 (40.9) 209 (28.9)
Career stage
  Trainee 167 (17.3) 50 (24.0) 115 (15.9)  < 0.001
  Non-trainee 760 (78.9) 156 (75.0) 600 (82.1)
  Did not answer 36 (3.74) 2 (1.0) 8 (1.1)
Location
  Rural 40 (4.4) 11 (5.4) 29 (4.2)  < 0.001
  Town 146 (16.2) 59 (28.9) 85 (12.2)
  Suburban 202 (22.4) 43 (21.1) 157 (22.6)
  City/metro 515 (57.0) 91 (44.6) 424 (61.0)

ICU intensive care unit, CCU coronary care unit, ER emergency room

*Chi-squared analysis

Non-physicians included physicians’ assistants, nurse practitioners, registered nurses, physical/occupational/respiratory therapists, and allied healthcare workers, i.e., medical technicians and certified nursing assistants

In multivariate analyses, redeployment was independently associated with higher odds of insomnia (2.00 [95% CI 1.29, 3.09], p < 0.001), anxiety (2.37 [95% CI 1.67, 3.37], p < 0.001), and depression (2.57 [95% CI 1.80, 3.68], p < 0.001) (Table 2).

Table 2.

Risk for Poor Sleep Quality, Insomnia, Anxiety, and Depression Among HCWs Redeployed Vs. Not Redeployed During August 31, 2020–September 15, 2020

Redeployed
(OR, 95% CI)
p value
Insomnia* 2.00 (1.29, 3.09)  < 0.001
Anxiety 2.37 (1.67, 3.37)  < 0.001
Depression 2.57 (1.80, 3.68)  < 0.001

Odds ratios were from logistic regression models used to test the effect of redeployment on the likelihood of developing one of the outcomes of interest controlling for age, sex, race, ethnicity, career stage, and profession, relationship status, and preexisting sleep disorders, anxiety disorder, or depressive disorder

OR odds ratio, CI confidence interval

*As measured by the Insomnia Severity Index (ISI); insomnia defined as ISI scores in the moderate to severe range (15–28)

Presence of anxiety was defined by a PHQ4 score of ≥ 3 for anxiety-specific questions

Presence of depression was defined by a PHQ4 score of ≥ 3 for depression-specific questions

DISCUSSION

Our results suggest that redeployment during the COVID-19 pandemic is associated with significant risk for insomnia, anxiety, and depression among healthcare workers even after controlling for many demographic factors. Given the chronic and relapsing nature of these conditions,4,5 it is important to consider that some health challenges of redeployment may have long-lasting consequences.

Limitations of this study include the dynamic nature of the healthcare workforce during this period. Many clinicians chose to switch jobs, including taking positions as traveling clinicians, or leaving healthcare altogether, and more left after our study period. Anxiety, depression, and insomnia may have influenced these decisions, which could limit generalizability. Although social media is widely utilized, using it as a means of recruitment may be considered a limitation. To combat time period bias, we asked participants to consider the month they were most clinically active caring for COVID-19 patients. While this may lead to bias, we felt it would be most representative of serving on the frontlines during the pandemic.

This is one of the first analyses of sleep and mental health effects of HCW redeployment. Considering our findings, future research should examine anxiety, depression, and insomnia in HCWs working outside of their scope of practice or in unfamiliar settings. Specifically, psychological and sleep hygiene support for these workers warrants examination. Positive leadership support6 and reserving redeployment as a last resort may be particularly important first steps for mitigating stress.

Funding

Dr. Vineet Arora is funded by National Heart, Lung and Blood Institute (NHLBI Grant K24HL136859).

Declarations

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Robbins JB, England E, Patel MD, et al. COVID-19 Impact on Well-Being and Education in Radiology Residencies: A Survey of the Association of Program Directors in Radiology. Acad Radiol. 2020;27(8):1162–1172. doi: 10.1016/j.acra.2020.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. SLEEP. 2011;34(5):601–608. doi: 10.1093/sleep/34.5.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009 Nov-Dec;50(6):613–21. 10.1176/appi.psy.50.6.613. PMID: 19996233. [DOI] [PubMed]
  • 4.Morin CM, Bélanger L, LeBlanc M, et al. The Natural History of Insomnia: A Population-Based 3-Year Longitudinal Study. Arch Intern Med. 2009;169(5):447–453. doi: 10.1001/archinternmed.2008.610. [DOI] [PubMed] [Google Scholar]
  • 5.Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand. 1991 Nov;84(5):446-52. 10.1111/j.1600-0447.1991.tb03176.x. PMID: 1776498. [DOI] [PubMed]
  • 6.Bliese, Paul D. and Britta, Thomas W. Social support, group consensus and stressor-strain relationships: social context matters. Journal of Organizational Behavior, 22, 2001 (10.1002/job.95)

Articles from Journal of General Internal Medicine are provided here courtesy of Society of General Internal Medicine

RESOURCES